List view / Grid view
25 April 2016 | By Victoria White, Drug Target Review
We've created an infographic on the threat of antibiotic resistance, highlighting some of the recommendations made by the Review on Antimicrobial Resistance to date...
22 April 2016 | By Victoria White, Digital Content Producer
Studying a new type of lab-grown mini-brain, Johns Hopkins researchers have confirmed a key way in which Zika virus causes microcephaly...
21 April 2016 | By Victoria White, Digital Content Producer
ARGX-115 targets the novel immuno-oncology target GARP, a protein believed to contribute to immunosuppressive effects of T-cells...
12 April 2016 | By Victoria White, Digital Content Producer
Researchers have discovered that interferon gamma could hold the key to understanding how harmful autoantibodies form in lupus patients...
12 April 2016 | By Merck KGaA
As a leading provider of antibodies for cell signaling research, EMD Millipore is advancing life science research and therapeutic development...
6 April 2016 | By Victoria White
The parties created IPS-MRCT Joint Centre for Therapeutic Antibodies in order to combine their expertise in research and development...
6 April 2016 | By Victoria White
Scientists have described the first-ever immature antibody found in a powerful class of immune molecules effective against HIV. TSRI biologist Jiang Zhu called the antibody a “teenager” and said it gives scientists a unique view of the steps needed to prompt the immune system to effectively target HIV...
30 March 2016 | By Victoria White
Neural stem cells that express AXL, only present during the 2nd trimester of pregnancy, may be linked to how Zika is able to produce cases of microcephaly...
Purification of tag-free proteins, a vital step for many research and industrial applications...
23 March 2016 | By Dr John Maher, Principal Investigator, National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Guy’s and St Thomas’ and Kings College London
Here, Dr John Maher of the NIHR BRC at Guy's and St Thomas' and Kings College London discusses CAR T-cell therapy and the exciting frontier the technique has opened up in the battle against cancer...
22 March 2016 | By Victoria White
Inovio’s DNA vaccine and dMAb products show potential to offer immediate and long term protection to large populations from CHIKV infection...
22 March 2016 | By Victoria White
Celyad is teaming up with the Inserm Unit of Institut Curie in Paris, France, to further develop its NKR-T pipeline in cellular immunotherapies for cancer...
21 March 2016 | By Victoria White
Ethris has announced the publication of data that underlines the broad therapeutic potential of the company’s proprietary mRNA transcript therapy platform...
17 March 2016 | By Merck KGaA
EMD Millipore offers an extensive, focused portfolio of immunoassays and validated antibodies for effective immunoprecipitation of chromatin, RNA-binding proteins, modified histones, and transcriptional proteins...
In this Antibodies In-depth Focus: Antibody fragment technology and avian IgY antibodies: a powerful combination; plus the challenges with antibody-based targeting of VEGF...
